Shalini Sri Ranganathan
Overview
Explore the profile of Shalini Sri Ranganathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
822
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guruparan Y, S Navaratinaraja T, Selvaratnam G, Sri Ranganathan S
BMJ Open Respir Res
. 2025 Feb;
12(1).
PMID: 40021202
Background: Inhaled corticosteroids (ICS) alone, or combined with long-acting beta-agonist (LABA), are recommended for chronic asthma. Limited access to inhaled medications hinders effective control of asthma in low-income and middle-income...
2.
Nadeshkumar A, Sathiadas G, Sri Ranganathan S
PLoS One
. 2023 Nov;
18(11):e0294690.
PMID: 37992067
Introduction: Oral liquid dosage forms remain popular in several middle income countries. The accuracy of liquid dosage form dosing depends on the accuracy and availability of measuring devices. Lack of...
3.
Sri Ranganathan S, Navaratinaraja T, Balasubramaniam R, Beneragama H
BMJ Open
. 2023 Feb;
13(2):e069733.
PMID: 36806061
Objective: To describe the price and affordability of key essential medicines for children in the private sector in Sri Lanka in 2017/2018, and compare the findings with 2009 data. Design:...
4.
Nadeshkumar A, Sathiadas G, Sri Ranganathan S
PLoS One
. 2022 Dec;
17(12):e0276379.
PMID: 36548310
Background: There are many paediatric specific challenges such as lack of age-appropriate dosage forms, inability of young children to swallow tablets and capsules and poor acceptability, during administration of oral...
5.
Guruparan Y, S Navaratinaraja T, Selvaratnam G, Gunawardena N, Sri Ranganathan S
BMC Pulm Med
. 2021 Sep;
21(1):295.
PMID: 34535111
Background: In the local setting, asthma control is assessed by symptoms and signs elicited by clinicians because of the limited availability of spirometry. Hence, we intended to develop a patient...
6.
Sri Ranganathan S, Wanigatunge C, Senadheera G, Beneragama B
PLoS One
. 2021 Sep;
16(9):e0257424.
PMID: 34520501
Introduction: Optimizing the use of antibacterial medicines is an accepted strategy to combat the antibacterial resistance. Availability of reliable antibacterial consumption (ABC) data is a prerequisite to implement this strategy....
7.
Sumanasena S, Wanigasinghe J, Arambepola C, Sri Ranganathan S, Muhandiram E
Eur J Paediatr Neurol
. 2021 Apr;
32:98-105.
PMID: 33894665
Objective: To assess the developmental progression and compare the developmental attainments of children treated with two hormonal therapies for infantile spasms (IS) over two years (seizure and EEG outcomes of...
8.
Wanigasinghe J, Arambepola C, Sri Ranganathan S, Jayasundara K, Weerasinghe A, Wickramarachchi P
Pediatr Neurol
. 2021 Apr;
119:22-26.
PMID: 33836476
Background: This article explores the role of initial treatment on control of spasms and other epilepsies at four years in children previously treated for West syndrome. Methods: The Sri Lanka...
9.
Lamontagne F, Stegemann M, Agarwal A, Agoritsas T, Siemieniuk R, Rochwerg B, et al.
BMJ
. 2021 Mar;
372:n526.
PMID: 33649077
Clinical Question: What is the role of drugs in preventing covid-19? WHY DOES THIS MATTER?: There is widespread interest in whether drug interventions can be used for the prevention of...
10.
Agarwal A, Hunt B, Stegemann M, Rochwerg B, Lamontagne F, Ac Siemieniuk R, et al.
BMJ
. 2020 Sep;
370:m3379.
PMID: 32887691
Updates: This is the fourteenth version (thirteenth update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will be published as updates to this guideline. Clinical...